This inventor holds 1 USPTO granted patent. Active years: 2024.
Years Active: 2024
Title: Ketan B Ghaghada: Innovator in Nanoparticle-Based Imaging Agents
Introduction
Ketan B Ghaghada is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of medical imaging through his innovative work on gadolinium nanoparticle contrast agents. His research focuses on enhancing the effectiveness of magnetic resonance imaging (MRI) techniques.
Latest Patents
Ketan B Ghaghada holds a patent for "Dual mode gadolinium nanoparticle contrast agents." This patent describes nanoparticle-based gadolinium (Gd) agents that can be utilized in T1-weighted MR imaging. The invention includes dual-Gd liposomal agents that feature both core-encapsulated Gd and surface-conjugated Gd. These agents have been shown to deliver higher concentrations of Gd, resulting in substantial improvements in signal-to-noise ratios and contrast-to-noise ratios. Additionally, the patent outlines methods for in vivo imaging and treating diseases such as cancer or tumors in subjects.
Career Highlights
Throughout his career, Ketan B Ghaghada has focused on advancing medical imaging technologies. His work has been instrumental in developing more effective imaging agents that can improve diagnostic capabilities in clinical settings. His innovative approach has garnered attention in the scientific community.
Collaborations
Ketan has collaborated with notable professionals in his field, including Vikas Kundra and James A Bankson. These collaborations have contributed to the development and refinement of his patented technologies.
Conclusion
Ketan B Ghaghada's contributions to the field of nanoparticle-based imaging agents represent a significant advancement in medical technology. His innovative work continues to impact the way diseases are diagnosed and treated, showcasing the importance of research and development in healthcare.